Sanara MedTech Inc. (NASDAQ:SMTI ) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.

Innoviz Technologies Ltd. (NASDAQ:INVZ ) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Ada Menaker - Corporate Participant Eldar Cegla - Chief Financial Officer Omer David Keilaf - Co-Founder, CEO & Director Conference Call Participants Casey Ryan - WestPark Capital, Inc., Research Division Colin William Rusch - Oppenheimer & Co. Inc., Research Division Kevin Garrigan - Rosenblatt Securities Inc., Research Division Mark Trevor Delaney - Goldman Sachs Group, Inc., Research Division Operator Ladies and gentlemen, thank you for standing by, and welcome to Innoviz's Second Quarter 2025 Earnings Call.

Tecogen Inc. (NYSE:TGEN ) Q2 2025 Earnings Conference Call August 13, 2025 9:30 AM ET Company Participants Abinand Rangesh - CEO & Director John Kimball Whiting - Corporate Participant General Counsel & Secretary - Corporate Participant Roger P. Deschenes - CFO, Treasurer & Chief Accounting Officer Conference Call Participants Alexander M.

KO's breakout above its 50-day SMA reflects strong demand, pricing power and global brand strength amid a premium valuation.

Aquiles Larrea turns to three companies he sees weathering storms of volatility in the long-term. He expects Caterpillar (CAT) to outperform due to continued infrastructure need in the U.S. Aquiles sees FedEx (FDX) as a value play with strong value, while listing Altria (MO) as a core holding that many investors "underestimate.

The iconic film company Kodak has been failing to capitalize on digital photography technology it invented in 1975, leading to bankruptcy and ongoing struggles.

Allurion Technologies Inc. (NYSE:ALUR ) Q2 2025 Earnings Conference Call August 13, 2025 8:30 AM ET Company Participants Shantanu K. Gaur - Co-Founder, CEO, President, Principal Financial & Accounting Officer and Director Tara Brady - Corporate Participant Conference Call Participants Joshua Thomas Jennings - TD Cowen, Research Division Keay Thomas Nakae - Chardan Capital Markets, LLC, Research Division Michael Toomey - Jefferies LLC, Research Division Operator Hello, and thank you for standing by.

Andean Precious Metals Corp. (OTCQX:ANPMF) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Alberto Morales - Founder, CEO & Executive Chairman Amanda Mallough - Corporate Participant Dom Kizek - Corporate Participant Juan Carlos Sandoval - Chief Financial Officer Yohann Bouchard - President & Director Conference Call Participants Allison Carson - Desjardins Securities Inc., Research Division Ben Pirie - Atrium Research Corporation Justin Chan - SCP Resource Finance LP, Research Division Operator Good morning, and welcome to Andean Precious Metals Second Quarter 2025 Results Conference Call. As a remainder, all participants are in the listen-only-mode.

SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Interactive Brokers launches its zero-commission IBKR Lite plan in Singapore, expanding global reach and fueling continued revenue growth.

FNV posts record Q2 revenues and profit on surging gold prices, with the EBITDA margin soaring to 99%.

Realty Income Corporation delivered a strong Q2 2025 performance with stable cash flows, high occupancy, growing dividends, and a bullish technical setup that signals breakout potential and long-term upside for investors.

European Wax Center, Inc. (NASDAQ:EWCZ ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Christopher D. Morris - CEO & Chairman Thomas Kim - Chief Financial Officer Conference Call Participants Dana Lauren Telsey - Telsey Advisory Group LLC John Edward Heinbockel - Guggenheim Securities, LLC, Research Division Jonathan Robert Komp - Robert W.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of National Grid plc (“National Grid” or the “Company”) (NYSE: NGG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. Rescheduling would reduce regulatory and banking risks, potentially unlocking new capital and investor interest, but both ETFs carry high fees and concentration risks. MJ is preferred over MSOS for its greater diversification, though both face challenges from high expense ratios and reliance on swaps.

Local Bounti Corporation (NYSE:LOCL ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Craig M. Hurlbert - Co-Founder & Executive Chairman of the Board Kathleen Valiasek - CEO, President & CFO Conference Call Participants Benjamin David Klieve - Lake Street Capital Markets, LLC, Research Division Kristen Owen - Oppenheimer & Co. Inc., Research Division Jeff Sonnek - ICR Inc. Operator Good morning, and welcome to Local Bounti's Second Quarter 2025 Earnings Conference Call.

Slight drops in production, revenue, EPS, and EBITDA, but costs fell and balance sheet stayed strong. The dividend payout is 75% of cash flow and the rest is used for debt repayment and 100% return of capital avoids US dividend tax. Debt $462M, low leverage (1.6x), bigger credit line, and preferred buyback boost flexibility.

Investor expectations for CoreWeave are high. Can the company continue justifying its stock price?